These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 19841506)
1. Gilbert's syndrome and antiviral therapy of hepatitis C. Deterding K; Grüngreiff K; Lankisch TO; Potthoff A; Bahr MJ; Manns MP; Wedemeyer H; Strassburg CP Ann Hepatol; 2009; 8(3):246-50. PubMed ID: 19841506 [TBL] [Abstract][Full Text] [Related]
2. The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin. Tahata Y; Hiramatsu N; Oze T; Morishita N; Harada N; Yamada R; Yakushijin T; Mita E; Hagiwara H; Yamada Y; Ito T; Hijioka T; Inada M; Katayama K; Tamura S; Yoshihara H; Inoue A; Imai Y; Irishio K; Kato M; Hikita H; Sakamori R; Miyagi T; Yoshida Y; Tatsumi T; Hamasaki T; Hayashi N; Takehara T J Gastroenterol; 2016 Mar; 51(3):252-9. PubMed ID: 26223482 [TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1. Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. Rogers CJ; Romagosa R; Vincek V J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524 [No Abstract] [Full Text] [Related]
5. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C. Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874 [TBL] [Abstract][Full Text] [Related]
6. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075 [TBL] [Abstract][Full Text] [Related]
7. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C]. Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727 [TBL] [Abstract][Full Text] [Related]
8. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin. Demirturk N; Aykin N; Demirdal T; Cevik F Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483 [No Abstract] [Full Text] [Related]
10. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy. Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182 [No Abstract] [Full Text] [Related]
11. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270 [TBL] [Abstract][Full Text] [Related]
12. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis. Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y Digestion; 2009; 79(1):36-9. PubMed ID: 19246919 [TBL] [Abstract][Full Text] [Related]
13. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C]. Shin MK; Kim TH; Ju K; Ha CY; Min HJ; Jung WT; Lee OJ Korean J Hepatol; 2009 Sep; 15(3):370-4. PubMed ID: 19783887 [TBL] [Abstract][Full Text] [Related]
14. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Antonini MG; Babudieri S; Maida I; Baiguera C; Zanini B; Fenu L; Dettori G; Manno D; Mura MS; Carosi G; Puoti M Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815 [TBL] [Abstract][Full Text] [Related]
15. Peginterferon and ribavirin for chronic hepatitis C. Hoofnagle JH; Seeff LB N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366 [No Abstract] [Full Text] [Related]
16. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553 [TBL] [Abstract][Full Text] [Related]
17. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients. Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850 [TBL] [Abstract][Full Text] [Related]
18. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C]. Enjoji M; Dainichi T; Gondo H; Urabe K Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079 [TBL] [Abstract][Full Text] [Related]
19. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C. Njouom R; Sartre MT; Timba I; Nerrienet E; Tchendjou P; Pasquier C; Rousset D J Med Virol; 2008 Dec; 80(12):2079-85. PubMed ID: 19040282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]